Replies to post #3338 on Enanta Pharmaceuticals Inc (ENTA)

[alertmeipp]

I thought the market was giving negative value for RSV programs anyways ;)

[dewophile]

Shionogi is targeting 2030 time frame for launch of their RSV L inhibitor per presentation materials released today in conjunction w earnings (slide 33):

https://www.shionogi.com/content/dam/shionogi/global/investors/ir-library/presentation/2024/%EF%BC%92q/E_FY2024_2Q_final.pdf